Advent of elexacaftor/tezacaftor/ivacaftor for cystic fibrosis treatment: What consequences on Aspergillus-related diseases? Preliminary insights
Adélaïde Chesnay, Éric Bailly, Laure Cosson, Thomas Flament, Guillaume Désoubeaux
Topics & Concepts
Allergic bronchopulmonary aspergillosisIvacaftorCystic fibrosisMedicineAspergillusCystic fibrosis transmembrane conductance regulatorImmunologyAspergillosisAllergyInternal medicineMicrobiologyBiologyImmunoglobulin EAntibodyCystic Fibrosis Research AdvancesAsthma and respiratory diseasesTracheal and airway disorders